# Standard Molecular, Inc. — Form D

Standard Molecular, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-04-24. The offering totals $5.7M, of which $1.4M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-04-24
- Form: D
- Accession: 0001738366-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.7M
- Amount sold: $1.4M
- Remaining: $4.2M
- Investors: 13
- Date of first sale: 2018-04-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-310836

## Issuer

- Name: Standard Molecular, Inc.
- CIK: 0001738366
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: ONE BROADWAY, CAMBRIDGE, MA, 02142
- Phone: 617-401-3318

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| David Artz | Director | Cambridge, MA |
| Andrew Smith | Director | Philadelphia, PA |
| Nathaniel Weiss | Director | Cambridge, MA |
| Nathaniel Weiss | Executive Officer | Cambridge, MA |

## More

- [CIK 1738366 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1738366&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001738366-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.